Financial reports
No filings
Current reports
No filings
Registration and prospectus
D/A
Indefinite amount in investment fund, sold $1.51 bn, 27 investors
29 Dec 23
D/A
Indefinite amount in investment fund, sold $1.51 bn, 27 investors
30 Dec 22
D/A
Indefinite amount in investment fund, sold $1.11B, 26 investors
4 Jan 22
D/A
Indefinite amount in investment fund, sold $675.08M, 24 investors
7 Jan 21
D/A
Indefinite amount in investment fund, sold $413.83M, 19 investors
10 Jan 20
D/A
Indefinite amount in investment fund, sold $224.03M, 18 investors
11 Jan 19
D/A
Indefinite amount in investment fund, sold $224.03M, 18 investors
8 Dec 17
D/A
Indefinite amount in investment fund, sold $212.03M, 17 investors
21 Sep 16
D/A
Indefinite amount in investment fund, sold $64.76M, 13 investors
12 Nov 14
D/A
Indefinite amount in investment fund, sold $41.66M, 14 investors
8 Nov 13
Proxies
DFAN14A
Additional proxy materials by non-management
23 Mar 09
DFAN14A
Additional proxy materials by non-management
20 Mar 09
DFAN14A
Additional proxy materials by non-management
13 Mar 09
DFAN14A
Additional proxy materials by non-management
13 Mar 09
DFAN14A
Additional proxy materials by non-management
12 Mar 09
DEFC14A
Proxy in contested solicitation
10 Mar 09
DFAN14A
Additional proxy materials by non-management
10 Mar 09
DFAN14A
Additional proxy materials by non-management
10 Feb 09
DFAN14A
Additional proxy materials by non-management
6 Feb 09
PRRN14A
Revised preliminary proxy statement filed by non-management
5 Feb 09
Ownership
SC 13D/A
MoonLake Immunotherapeutics
5 Mar 24
SC 13G/A
enGene Holdings Inc.
22 Feb 24
SC 13G/A
Aclaris Therapeutics, Inc.
14 Feb 24
SC 13G/A
AILERON THERAPEUTICS INC
14 Feb 24
SC 13G/A
Annexon, Inc.
14 Feb 24
SC 13G/A
Aravive, Inc.
14 Feb 24
SC 13G/A
ASLAN Pharmaceuticals Ltd
14 Feb 24
SC 13G/A
BIONOMICS LIMITED/FI
14 Feb 24
SC 13G/A
Cidara Therapeutics, Inc.
14 Feb 24
SC 13G/A
Cullinan Oncology, Inc.
14 Feb 24